Effects of Selenium and/or N-Acetyl-Cysteine Supplementation on Nonthyroidal Illness Syndrome in Hemodialysis Patients: A Factorial Randomized Controlled Trial.
- 2022
- RCT
- Pharmacology 107(9-10)
- Elham Shahreki
- Mahmoud Ali Kaykhaei
- Zahra Mosallanezhad
- Zahra Adineh
- Ali Mohammad Mokhtari
- Mahdi Mohammadi
- Razieh Hosseini
- Razieh Hosseini
- Aliyeh Bazi
- PubMed: 35691282
- DOI: 10.1159/000525094
- High evidence
- Clinical
Although there were no significant differences in FT3 (p = 0.39) ... between the groups at the end of the trial.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 200 μg per day